Author:
Mote Patricia A.,Gompel Anne,Howe Chris,Hilton Heidi N.,Sestak Ivana,Cuzick Jack,Dowsett Mitch,Hugol Danielle,Forgez Patricia,Byth Karen,Graham J. Dinny,Clarke Christine L.
Funder
National Health and Medical Research Council
Publisher
Springer Science and Business Media LLC
Reference37 articles.
1. Santen RJ (2003) Risk of breast cancer with progestins: critical assessment of current data. Steroids 68(10–13):953–964. doi: 10.1016/S0039-128X(03)00138-7
2. Persson I (2000) Estrogens in the causation of breast, endometrial and ovarian cancers—evidence and hypotheses from epidemiological findings. J Steroid Biochem Mol Biol 74(5):357–364
3. Brisken C (2013) Progesterone signalling in breast cancer: a neglected hormone coming into the limelight. Nat Rev Cancer 13(6):385–396. doi: 10.1038/nrc3518
4. Chlebowski RT, Kuller LH, Prentice RL, Stefanick ML, Manson JE, Gass M, Aragaki AK, Ockene JK, Lane DS, Sarto GE, Rajkovic A, Schenken R, Hendrix SL, Ravdin PM, Rohan TE, Yasmeen S, Anderson G (2009) Breast cancer after use of estrogen plus progestin in postmenopausal women. N Engl J Med 360(6):573–587. doi: 10.1056/NEJMoa0807684
5. Mote PA, Balleine RL, McGowan EM, Clarke CL (1999) Colocalization of progesterone receptors A and B by dual immunofluorescent histochemistry in human endometrium during the menstrual cycle. J Clin Endocrinol Metab 84(8):2963–2971
Cited by
40 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献